Paola Dama

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Cancer gene therapy

Communications biology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tom Stiff, Salih Bayraktar, Paola Dama, Justin Stebbing, Castellano L
CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth. Communications biology 7 (1) (2024)
Tom Stiff, Salih Bayraktar, Paola Dama, Justin Stebbing, Castellano L
CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth. Communications biology 7 (1) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy (2024)
Tom Stiff, Salih Bayraktar, Paola Dama, Justin Stebbing, Castellano L
CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth. Communications biology 7 (1) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy (2024)
Mohsen Sheykhhasan, Hamed Manoochehri, Paola Dama
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study. Cancer gene therapy 29 (8-9) (2022)
Nikolaos Sideris, Paola Dama, Salih Bayraktar, Thomas Stiff, Leandro Castellano
LncRNAs in breast cancer: a link to future approaches. Cancer gene therapy (2022)
Paola Dama, Marshall Tang, Noreen Fulton, Justin Kline, Hongtao Liu
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy. Journal for immunotherapy of cancer 7 (1) (2019)